A lyophilized anti-fungal composition comprises (A) caspofungin, or a pharmaceutically acceptable salt thereof, in an effective amount； (B) one or more non-reducing sugars having a glass transition temperature Tg(s) of at least about 90° C.； and (C) an acetate buffer in an amount effective to provide a pH in a range of from about 5 to about 7； wherein the weight ratio of the one or more non-reducing sugars to caspofungin is in a range of from about 1.1:1 to about 10:1； the composition has a moisture content of about 0.8 wt. % or less； and the composition has a glass transition temperature Tg(c) of at least about 55° C. The lyophilized composition has good storage stability at temperatures up to and including room temperature. The composition can be reconstituted for use in preventing or treating fungal infections.
